News

Using metformin within 3 months of infection may reduce long COVID risk

Starting the diabetes drug metformin within 90 days of SARS-CoV-2 infection decreased the risk for developing long COVID by ...

XFG ‘Stratus' COVID variant spreading rapidly in U.S. as cases surge

The XFG COVID-19 variant, aka "Stratus," is spreading rapidly in the U.S. as cases climb. Here's what to know about symptoms ...
Pulmonology Advisor

Azelastine Nasal Spray Reduces Risk for SARS-CoV-2 Infection

Azelastine nasal spray is associated with a reduced risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.